The widening controversy over access to abortion medications draws a Congressional query to UPS, FedEx and DHL
Numerous state laws have been passed or proposed in the wake of the US Supreme Court's decision to remove constitutional protections to abortion. Potentially, these laws could enable prosecutors to gain access to who has provided access to, or received, abortion medications. One response, from a group of members of the US Congress, is to seek meetings with package delivery companies "to ensure individuals' rights to privacy and protection against unreasonable search and seizure are upheld" by the delivery companies, according to a statement by the Representatives (Raja Krishnamoorthi [D-IL], Dean Phillips [D-MN], Ayanna Pressley [D-MA], Katie Porter [D-CA] and Cori Bush [D-MO]).
Some abortion medications are available over the counter, depending on the state; other states require a physician’s or pharmacist’s authorization. Mail order is possible in most cases. A variety of anti-abortion medications are FDA-approved—which precludes states making possession of them illegal. Meanwhile, the intent of some anti-abortion state laws is to enable criminal investigation of the delivery or use of such medications; even telemedicine is being drawn into the controversy. Even before some of these laws are tested for their constitutional legality, the five Representatives want to clarify how the delivery companies will meet such investigations. Specifically, they want policies to require search warrants before access to shipments are granted; to not voluntarily reveal such shipments; to control and quickly delete data recording such shipments; and to limit the collection of such data.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.